HomeIMVT • NASDAQ
add
Immunovant Inc
Previous close
$28.61
Day range
$28.40 - $29.54
Year range
$15.90 - $45.58
Market cap
4.18B USD
Avg Volume
1.19M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 61.55M | 13.93% |
Net income | -51.42M | 18.68% |
Net profit margin | — | — |
Earnings per share | -0.36 | 26.53% |
EBITDA | -61.50M | -13.93% |
Effective tax rate | 0.21% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 690.94M | 59.71% |
Total assets | 711.45M | 55.94% |
Total liabilities | 32.10M | -22.77% |
Total equity | 679.34M | — |
Shares outstanding | 145.29M | — |
Price to book | 6.11 | — |
Return on assets | -30.67% | — |
Return on capital | -33.02% | — |
Cash Flow
Net change in cash
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -51.42M | 18.68% |
Cash from operations | -47.10M | -1.52% |
Cash from investing | -131.00K | -33.67% |
Cash from financing | 469.84M | 565.21% |
Net change in cash | 421.01M | 1,468.88% |
Free cash flow | -34.79M | -104.61% |
About
Founded
2018
Website
Employees
164